Skip to main content

Table 4 Plasma hTERT mRNA in NPC patients at stages III and IV before and after treatment

From: Joint quantitative measurement of hTERT mRNA in both peripheral blood and circulating tumor cells of patients with nasopharyngeal carcinoma and its clinical significance

Group

n

hTERT mRNA (2-△△Ct) −(X Â± SD)

F value

P value

Before treatment

24

12.68 Â± 3.08

98.528

<0.001

After chemotherapy

24

10.68 Â± 2.48

After chemotherapy and radiotherapy

24

3.13 Â± 1.69